Fig. 2.
The baseline levels of Treg phenotype expressing CD4+CD25high+ in the peripheral blood of granulocyte and monocyte/macrophage by extracorporeal adsorption (GMA) responder and non-responder patients. It is inferred that patients with compromised CD4+CD25high+ Treg at baseline are not likely to respond to the Adacolumn GMA, while patients with a fair level of CD4+CD25high+ Treg at baseline are likely to respond to GMA.